HUM
HUMANA INC
Company overview
- Market capitalization
- $46.79B
- Employees
- 67,060
- Latest publication
- 2026-09-29
About HUMANA INC
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 40,867,000,000USD | 39,648,000,000USD | 32,649,000,000USD | 32,388,000,000USD | 32,112,000,000USD | 29,397,000,000USD | 29,540,000,000USD | 29,611,000,000USD |
| Selling General Administrative | 3,978,000,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 3,978,000,000USD | 4,362,000,000USD | 4,550,000,000USD | 4,101,000,000USD | 3,929,000,000USD | 3,642,000,000USD | 3,600,000,000USD | 3,497,000,000USD |
| Operating Income | 1,360,000,000USD | 1,579,000,000USD | 108,000,000USD | 722,000,000USD | 1,648,000,000USD | 635,000,000USD | 901,000,000USD | 990,000,000USD |
| Total Other Income Expense Net | -408,000,000USD | -159,000,000USD | -26,000,000USD | -19,000,000USD | -366,000,000USD | -16,000,000USD | -17,000,000USD | -24,000,000USD |
| Interest Expense | 197,000,000USD | 193,000,000USD | 168,000,000USD | 157,000,000USD | 160,000,000USD | 169,000,000USD | 168,000,000USD | 159,000,000USD |
| Income Before Tax | 952,000,000USD | 1,579,000,000USD | 108,000,000USD | 722,000,000USD | 1,648,000,000USD | 635,000,000USD | 901,000,000USD | 990,000,000USD |
| Income Tax Expense | 238,000,000USD | 395,000,000USD | -86,000,000USD | 179,000,000USD | 406,000,000USD | 155,000,000USD | 223,000,000USD | 251,000,000USD |
| Equity Method Income Loss | -21,000,000USD | — | — | — | — | — | — | — |
| Net Income | 693,000,000USD | 1,186,000,000USD | 195,000,000USD | 545,000,000USD | 1,244,000,000USD | 480,000,000USD | 679,000,000USD | 741,000,000USD |
| Minority Interest | -1,000,000USD | 2,000,000USD | 1,000,000USD | 2,000,000USD | 2,000,000USD | 0USD | 1,000,000USD | 2,000,000USD |
| Net Income Applicable To Common Shares | 694,000,000USD | — | 195,000,000USD | 545,000,000USD | 1,244,000,000USD | 480,000,000USD | — | — |
| Cost Of Revenue | — | 33,707,000,000USD | 27,991,000,000USD | 27,565,000,000USD | 26,535,000,000USD | 25,120,000,000USD | 25,039,000,000USD | 25,124,000,000USD |
| Gross Profit | — | 5,941,000,000USD | 4,658,000,000USD | 4,823,000,000USD | 5,577,000,000USD | 4,277,000,000USD | 4,501,000,000USD | 4,487,000,000USD |
| Unclassified Operating Expenses | — | 4,362,000,000USD | 4,550,000,000USD | 4,101,000,000USD | 3,929,000,000USD | 3,642,000,000USD | 3,600,000,000USD | 3,497,000,000USD |
| Net Interest Income | — | -193,000,000USD | -168,000,000USD | -157,000,000USD | -160,000,000USD | -169,000,000USD | -168,000,000USD | -159,000,000USD |
| Tax Provision | — | 395,000,000USD | -86,000,000USD | 179,000,000USD | 406,000,000USD | 155,000,000USD | 223,000,000USD | 251,000,000USD |
| Net Income From Continuing Ops | — | 1,184,000,000USD | 194,000,000USD | 543,000,000USD | 1,242,000,000USD | 480,000,000USD | 678,000,000USD | 739,000,000USD |
| Ebit | — | 1,772,000,000USD | 276,000,000USD | 879,000,000USD | 1,808,000,000USD | 804,000,000USD | 1,069,000,000USD | 1,149,000,000USD |
| Ebitda | — | 1,966,000,000USD | 480,000,000USD | 1,090,000,000USD | 2,023,000,000USD | 1,047,000,000USD | 1,312,000,000USD | 1,391,000,000USD |
| Depreciation And Amortization | — | 194,000,000USD | 204,000,000USD | 211,000,000USD | 215,000,000USD | 243,000,000USD | 243,000,000USD | 242,000,000USD |
| Reconciled Depreciation | — | 194,000,000USD | 204,000,000USD | 211,000,000USD | 215,000,000USD | 243,000,000USD | 243,000,000USD | 242,000,000USD |
| Interest Income | — | — | 168,000,000USD | 157,000,000USD | 160,000,000USD | 169,000,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 117,811,000,000USD | 106,440,000,000USD | 92,922,000,000USD | 83,648,000,000USD | 77,191,000,000USD | 64,933,000,000USD | 56,944,000,000USD | 53,800,000,000USD |
| Cost Of Revenue | 100,664,000,000USD | 88,394,000,000USD | 75,690,000,000USD | 69,199,000,000USD | 61,501,000,000USD | 53,740,000,000USD | 45,753,000,000USD | 43,389,000,000USD |
| Gross Profit | 17,147,000,000USD | 18,046,000,000USD | 17,232,000,000USD | 14,449,000,000USD | 15,690,000,000USD | 11,193,000,000USD | 11,191,000,000USD | 7,085,000,000USD |
| Selling General Administrative | 248,000,000USD | 265,000,000USD | — | 10,121,000,000USD | 10,052,000,000USD | 7,381,000,000USD | 7,525,000,000USD | 6,567,000,000USD |
| Unclassified Operating Expenses | 15,272,000,000USD | 14,461,000,000USD | 13,668,000,000USD | 909,000,000USD | 964,000,000USD | 342,000,000USD | 1,592,000,000USD | 518,000,000USD |
| Total Operating Expenses | 15,520,000,000USD | 14,726,000,000USD | 13,668,000,000USD | 11,030,000,000USD | 11,016,000,000USD | 7,723,000,000USD | 9,117,000,000USD | 7,085,000,000USD |
| Operating Income | 1,627,000,000USD | 3,320,000,000USD | 3,564,000,000USD | 3,419,000,000USD | 4,674,000,000USD | 3,470,000,000USD | 2,074,000,000USD | 3,326,000,000USD |
| Interest Income | 660,000,000USD | 493,000,000USD | 401,000,000USD | 326,000,000USD | 283,000,000USD | 242,000,000USD | 218,000,000USD | 242,000,000USD |
| Interest Expense | 660,000,000USD | 493,000,000USD | 401,000,000USD | 326,000,000USD | 283,000,000USD | 242,000,000USD | 218,000,000USD | 242,000,000USD |
| Net Interest Income | -660,000,000USD | -493,000,000USD | -401,000,000USD | -326,000,000USD | -283,000,000USD | -242,000,000USD | -218,000,000USD | -242,000,000USD |
| Income Before Tax | 1,627,000,000USD | 3,320,000,000USD | 3,564,000,000USD | 3,419,000,000USD | 4,674,000,000USD | 3,470,000,000USD | 2,074,000,000USD | 4,020,000,000USD |
| Income Tax Expense | 413,000,000USD | 836,000,000USD | 762,000,000USD | 485,000,000USD | 1,307,000,000USD | 763,000,000USD | 391,000,000USD | 1,572,000,000USD |
| Tax Provision | 413,000,000USD | 836,000,000USD | 762,000,000USD | 485,000,000USD | 1,307,000,000USD | 763,000,000USD | 391,000,000USD | 1,572,000,000USD |
| Net Income | 1,207,000,000USD | 2,489,000,000USD | 2,806,000,000USD | 2,933,000,000USD | 3,367,000,000USD | 2,707,000,000USD | 1,683,000,000USD | 2,448,000,000USD |
| Net Income From Continuing Ops | 1,214,000,000USD | 2,484,000,000USD | 2,802,000,000USD | 2,934,000,000USD | 3,293,000,000USD | 2,693,000,000USD | 2,454,000,000USD | 5,592,000,000USD |
| Ebit | 2,287,000,000USD | 3,813,000,000USD | 3,965,000,000USD | 3,745,000,000USD | 4,957,000,000USD | 3,712,000,000USD | 2,292,000,000USD | -1,421,000,000USD |
| Ebitda | 3,255,000,000USD | 4,730,000,000USD | 4,810,000,000USD | 4,458,000,000USD | 5,573,000,000USD | 4,287,000,000USD | 2,826,000,000USD | -936,000,000USD |
| Depreciation And Amortization | 968,000,000USD | 917,000,000USD | 845,000,000USD | 713,000,000USD | 616,000,000USD | 575,000,000USD | 534,000,000USD | 485,000,000USD |
| Reconciled Depreciation | 968,000,000USD | 917,000,000USD | 845,000,000USD | 713,000,000USD | 616,000,000USD | 575,000,000USD | 534,000,000USD | 485,000,000USD |
| Total Other Income Expense Net | -94,000,000USD | -63,000,000USD | -4,000,000USD | 65,000,000USD | 74,000,000USD | 278,000,000USD | -1,026,000,000USD | 10,411,000,000USD |
| Minority Interest | -7,000,000USD | 5,000,000USD | 4,000,000USD | -1,000,000USD | 0USD | — | — | — |
| Net Income Applicable To Common Shares | 1,207,000,000USD | 2,489,000,000USD | 2,806,000,000USD | 2,933,000,000USD | 3,367,000,000USD | 2,707,000,000USD | 1,683,000,000USD | 2,448,000,000USD |
| Non Operating Income Net Other | — | — | 165,000,000USD | 597,000,000USD | -29,000,000USD | 520,000,000USD | -819,000,000USD | — |
| Research Development | — | — | — | — | — | — | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 57,196,000,000USD | 55,280,000,000USD | 48,750,000,000USD | 49,719,000,000USD | 50,357,000,000USD | 50,930,000,000USD | 46,312,000,000USD | 50,007,000,000USD |
| Cash And Equivalents | 6,893,000,000USD | — | 4,200,000,000USD | 5,388,000,000USD | 4,040,000,000USD | 4,250,000,000USD | 2,221,000,000USD | 5,116,000,000USD |
| Cash And Short Term Investments | 23,871,000,000USD | 21,965,000,000USD | 4,200,000,000USD | 5,388,000,000USD | 4,040,000,000USD | 4,250,000,000USD | 2,221,000,000USD | 5,116,000,000USD |
| Short Term Investments | 16,978,000,000USD | 17,014,000,000USD | 15,703,000,000USD | 16,736,000,000USD | 17,668,000,000USD | 17,888,000,000USD | 18,214,000,000USD | 19,033,000,000USD |
| Total Current Assets | 40,086,000,000USD | 27,183,000,000USD | 7,470,000,000USD | 8,072,000,000USD | 8,544,000,000USD | 8,709,000,000USD | 4,925,000,000USD | 7,260,000,000USD |
| Other Current Assets | 10,520,000,000USD | 10,897,000,000USD | 9,560,000,000USD | -24,808,000,000USD | -26,212,000,000USD | -26,597,000,000USD | -23,139,000,000USD | -26,293,000,000USD |
| Other Non Current Assets | 3,250,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 37,919,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 23,007,000,000USD | 21,507,000,000USD | 10,314,000,000USD | 10,353,000,000USD | 11,334,000,000USD | 12,293,000,000USD | 11,257,000,000USD | 12,456,000,000USD |
| Other Non Current Liabilities | 2,933,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 19,213,000,000USD | 18,580,000,000USD | 17,657,000,000USD | 18,522,000,000USD | 18,234,000,000USD | 17,751,000,000USD | 16,375,000,000USD | 17,565,000,000USD |
| Total Equity Including Noncontrolling Interest | 19,277,000,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 11,979,000,000USD | 12,274,000,000USD | 12,369,000,000USD | 12,607,000,000USD | 12,586,000,000USD | 12,729,000,000USD | 11,144,000,000USD | 11,886,000,000USD |
| Deferred Revenue | 249,000,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 2,098,000,000USD | 2,170,000,000USD | 2,716,000,000USD | 2,268,000,000USD | 2,356,000,000USD | 2,427,000,000USD | 2,977,000,000USD | 2,693,000,000USD |
| Goodwill | 10,485,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 1,180,000,000USD | — | 1,128,000,000USD | 1,230,000,000USD | 1,380,000,000USD | 1,427,000,000USD | 1,443,000,000USD | 1,650,000,000USD |
| Accounts Payable | 7,263,000,000USD | 19,222,000,000USD | 9,808,000,000USD | 10,088,000,000USD | 11,060,000,000USD | 11,451,000,000USD | 10,273,000,000USD | 11,125,000,000USD |
| Short Term Debt | 2,268,000,000USD | 1,719,000,000USD | 150,000,000USD | 0USD | 0USD | 577,000,000USD | 724,000,000USD | 1,136,000,000USD |
| Common Stock | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD |
| Retained Earnings | 30,741,000,000USD | 30,153,000,000USD | 29,075,000,000USD | 29,980,000,000USD | 29,891,000,000USD | 29,453,000,000USD | 28,317,000,000USD | 29,118,000,000USD |
| Accumulated Other Comprehensive Income | -751,000,000USD | -731,000,000USD | -633,000,000USD | -666,000,000USD | -783,000,000USD | -868,000,000USD | -1,067,000,000USD | -653,000,000USD |
| Total Liab | — | 36,634,000,000USD | 31,013,000,000USD | 31,137,000,000USD | 32,062,000,000USD | 33,111,000,000USD | 29,867,000,000USD | 32,383,000,000USD |
| Other Current Liab | — | 566,000,000USD | 6,023,000,000USD | 308,000,000USD | -16,647,000,000USD | -17,408,000,000USD | -16,276,000,000USD | -18,176,000,000USD |
| Capital Stock | — | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD |
| Good Will | — | 10,489,000,000USD | 9,686,000,000USD | 9,619,000,000USD | 9,633,000,000USD | 9,631,000,000USD | 9,631,000,000USD | 9,590,000,000USD |
| Cash | — | 4,951,000,000USD | 4,200,000,000USD | 5,388,000,000USD | 4,040,000,000USD | 4,250,000,000USD | 2,221,000,000USD | 5,116,000,000USD |
| Current Deferred Revenue | — | 269,000,000USD | 356,000,000USD | 265,000,000USD | 274,000,000USD | 265,000,000USD | 260,000,000USD | 195,000,000USD |
| Net Debt | — | 9,042,000,000USD | 8,737,000,000USD | 7,219,000,000USD | 8,546,000,000USD | 9,056,000,000USD | 10,039,000,000USD | 7,906,000,000USD |
| Short Long Term Debt | — | 1,719,000,000USD | 0USD | 0USD | 0USD | 577,000,000USD | 577,000,000USD | 1,136,000,000USD |
| Short Long Term Debt Total | — | 13,993,000,000USD | 12,937,000,000USD | 12,607,000,000USD | 12,586,000,000USD | 13,306,000,000USD | 12,260,000,000USD | 13,022,000,000USD |
| Long Term Investments | — | 18,273,000,000USD | 16,834,000,000USD | 17,799,000,000USD | 18,735,000,000USD | 18,957,000,000USD | 19,332,000,000USD | 20,162,000,000USD |
| Net Receivables | — | 5,218,000,000USD | 3,270,000,000USD | 2,684,000,000USD | 4,504,000,000USD | 4,459,000,000USD | 2,704,000,000USD | 2,144,000,000USD |
| Common Stock Shares Outstanding | — | 120,652,000shares | 120,339,000shares | 120,778,000shares | 120,745,000shares | 120,764,000shares | 120,764,000shares | 120,764,000shares |
| Non Current Assets Total | — | 28,097,000,000USD | 41,280,000,000USD | 41,647,000,000USD | 41,813,000,000USD | 42,221,000,000USD | 41,387,000,000USD | 42,747,000,000USD |
| Non Current Liabilities Total | — | 15,127,000,000USD | 20,699,000,000USD | 20,784,000,000USD | 20,728,000,000USD | 20,818,000,000USD | 18,610,000,000USD | 19,927,000,000USD |
| Non Currrent Assets Other | — | 14,179,000,000USD | 10,832,000,000USD | 10,731,000,000USD | 9,709,000,000USD | 9,779,000,000USD | 7,744,000,000USD | 8,652,000,000USD |
| Unclassified Current Assets | — | -10,897,000,000USD | -25,263,000,000USD | -16,736,000,000USD | -17,668,000,000USD | -17,888,000,000USD | -18,214,000,000USD | -19,033,000,000USD |
| Unclassified Non Current Assets | — | -17,014,000,000USD | — | -49,719,000,000USD | -50,357,000,000USD | -50,930,000,000USD | -46,219,000,000USD | -50,007,000,000USD |
| Unclassified Current Liabilities | — | -1,988,000,000USD | -6,023,000,000USD | -308,000,000USD | — | -577,000,000USD | -577,000,000USD | -1,136,000,000USD |
| Unclassified Non Current Liabilities | — | 2,853,000,000USD | 8,330,000,000USD | 8,177,000,000USD | 8,142,000,000USD | 8,089,000,000USD | 7,466,000,000USD | 8,041,000,000USD |
| Unclassified Equity | — | -10,908,000,000USD | -10,851,000,000USD | -10,858,000,000USD | -10,940,000,000USD | -10,900,000,000USD | -10,941,000,000USD | -10,966,000,000USD |
| Other Assets | — | — | — | 49,719,000,000USD | 50,357,000,000USD | 50,930,000,000USD | 46,479,000,000USD | 50,007,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 48,750,000,000USD | 46,312,000,000USD | 46,892,000,000USD | 43,725,000,000USD | 44,748,000,000USD | 35,077,000,000USD | 29,043,000,000USD | 25,344,000,000USD |
| Intangible Assets | 1,128,000,000USD | 1,443,000,000USD | 1,693,000,000USD | 1,765,000,000USD | 2,639,000,000USD | 329,000,000USD | 177,000,000USD | 245,000,000USD |
| Other Current Assets | 9,560,000,000USD | -23,139,000,000USD | -23,355,000,000USD | -20,616,000,000USD | -18,400,000,000USD | -18,365,000,000USD | -16,082,000,000USD | -1,015,000,000USD |
| Total Liab | 31,013,000,000USD | 29,867,000,000USD | 30,574,000,000USD | 28,355,000,000USD | 28,645,000,000USD | 21,349,000,000USD | 17,006,000,000USD | 15,183,000,000USD |
| Total Stockholder Equity | 17,657,000,000USD | 16,375,000,000USD | 16,262,000,000USD | 15,311,000,000USD | 16,080,000,000USD | 13,728,000,000USD | 12,037,000,000USD | 10,161,000,000USD |
| Other Current Liab | 6,023,000,000USD | -16,276,000,000USD | -18,253,000,000USD | -17,693,000,000USD | -14,751,000,000USD | -12,756,000,000USD | -10,457,000,000USD | 8,100,000,000USD |
| Common Stock | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD |
| Capital Stock | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD | 33,000,000USD |
| Retained Earnings | 29,075,000,000USD | 28,317,000,000USD | 27,540,000,000USD | 25,492,000,000USD | 23,086,000,000USD | 20,517,000,000USD | 17,483,000,000USD | 15,072,000,000USD |
| Good Will | 9,686,000,000USD | 9,631,000,000USD | 9,550,000,000USD | 9,142,000,000USD | 11,092,000,000USD | 4,447,000,000USD | 3,928,000,000USD | 3,897,000,000USD |
| Cash | 4,200,000,000USD | 2,221,000,000USD | 4,694,000,000USD | 5,061,000,000USD | 3,394,000,000USD | 4,673,000,000USD | 4,054,000,000USD | 2,343,000,000USD |
| Cash And Equivalents | 4,200,000,000USD | 2,221,000,000USD | 4,694,000,000USD | 5,061,000,000USD | 3,394,000,000USD | 4,673,000,000USD | 4,054,000,000USD | 2,343,000,000USD |
| Cash And Short Term Investments | 4,200,000,000USD | 2,221,000,000USD | 4,694,000,000USD | 5,061,000,000USD | 3,394,000,000USD | 4,673,000,000USD | 4,054,000,000USD | 2,343,000,000USD |
| Total Current Assets | 7,470,000,000USD | 4,925,000,000USD | 6,729,000,000USD | 6,735,000,000USD | 5,208,000,000USD | 5,811,000,000USD | 5,110,000,000USD | 3,358,000,000USD |
| Total Current Liabilities | 10,314,000,000USD | 11,257,000,000USD | 11,946,000,000USD | 11,632,000,000USD | 10,493,000,000USD | 8,996,000,000USD | 6,799,000,000USD | 6,525,000,000USD |
| Current Deferred Revenue | 356,000,000USD | 260,000,000USD | 266,000,000USD | 286,000,000USD | 254,000,000USD | 318,000,000USD | 247,000,000USD | 283,000,000USD |
| Net Debt | 8,737,000,000USD | 10,039,000,000USD | 7,575,000,000USD | 6,692,000,000USD | 9,831,000,000USD | 2,471,000,000USD | 2,060,000,000USD | 3,726,000,000USD |
| Short Term Debt | 150,000,000USD | 724,000,000USD | 1,612,000,000USD | 2,263,000,000USD | 2,138,000,000USD | 729,000,000USD | 815,000,000USD | 1,694,000,000USD |
| Short Long Term Debt | 0USD | 577,000,000USD | 1,796,000,000USD | 2,390,000,000USD | 2,279,000,000USD | 920,000,000USD | 924,000,000USD | 1,865,000,000USD |
| Short Long Term Debt Total | 12,937,000,000USD | 12,260,000,000USD | 12,269,000,000USD | 11,753,000,000USD | 13,225,000,000USD | 7,144,000,000USD | 6,114,000,000USD | 6,069,000,000USD |
| Long Term Debt | 12,369,000,000USD | 11,144,000,000USD | 10,213,000,000USD | 9,034,000,000USD | 10,541,000,000USD | 6,060,000,000USD | 4,967,000,000USD | 4,375,000,000USD |
| Long Term Investments | 16,834,000,000USD | 19,332,000,000USD | 17,748,000,000USD | 15,010,000,000USD | 14,113,000,000USD | 2,382,000,000USD | 1,469,000,000USD | 1,458,000,000USD |
| Short Term Investments | 15,703,000,000USD | 18,214,000,000USD | 16,626,000,000USD | 13,881,000,000USD | 13,192,000,000USD | 12,554,000,000USD | 10,972,000,000USD | 10,026,000,000USD |
| Net Receivables | 3,270,000,000USD | 2,704,000,000USD | 2,035,000,000USD | 1,674,000,000USD | 1,814,000,000USD | 1,138,000,000USD | 1,056,000,000USD | 1,015,000,000USD |
| Accounts Payable | 9,808,000,000USD | 10,273,000,000USD | 10,068,000,000USD | 9,083,000,000USD | 8,101,000,000USD | 7,949,000,000USD | 5,737,000,000USD | 4,548,000,000USD |
| Property Plant Equipment Net | 2,716,000,000USD | 2,977,000,000USD | 3,540,000,000USD | 3,736,000,000USD | 3,751,000,000USD | 2,808,000,000USD | 2,365,000,000USD | 1,735,000,000USD |
| Accumulated Other Comprehensive Income | -633,000,000USD | -1,067,000,000USD | -999,000,000USD | -1,304,000,000USD | 42,000,000USD | 391,000,000USD | 156,000,000USD | -159,000,000USD |
| Common Stock Shares Outstanding | 120,826,000shares | 120,869,000shares | 124,441,000shares | 127,094,000shares | 129,396,000shares | 133,012,000shares | 134,726,998shares | 138,402,998shares |
| Non Current Assets Total | 41,280,000,000USD | 41,387,000,000USD | 40,163,000,000USD | 36,990,000,000USD | 39,540,000,000USD | 29,266,000,000USD | 23,933,000,000USD | 21,986,000,000USD |
| Non Current Liabilities Total | 20,699,000,000USD | 18,610,000,000USD | 18,628,000,000USD | 16,723,000,000USD | 18,152,000,000USD | 12,353,000,000USD | 10,207,000,000USD | 8,658,000,000USD |
| Non Currrent Assets Other | 10,832,000,000USD | 7,744,000,000USD | 7,584,000,000USD | 6,486,000,000USD | 7,367,000,000USD | 6,444,000,000USD | 4,786,000,000USD | 4,380,000,000USD |
| Unclassified Current Assets | -25,263,000,000USD | -18,214,000,000USD | -16,626,000,000USD | -13,881,000,000USD | -13,192,000,000USD | -12,554,000,000USD | -10,972,000,000USD | -10,026,000,000USD |
| Unclassified Current Liabilities | -6,023,000,000USD | -577,000,000USD | -1,796,000,000USD | -2,390,000,000USD | -2,279,000,000USD | -920,000,000USD | -924,000,000USD | -9,965,000,000USD |
| Unclassified Non Current Liabilities | 8,330,000,000USD | 7,466,000,000USD | 8,415,000,000USD | 5,199,000,000USD | 2,857,000,000USD | 2,719,000,000USD | 3,290,000,000USD | 2,683,000,000USD |
| Unclassified Equity | -10,851,000,000USD | -10,941,000,000USD | -10,345,000,000USD | -8,943,000,000USD | 3,049,000,000USD | 2,672,000,000USD | 2,787,000,000USD | 2,502,000,000USD |
| Other Assets | — | 46,479,000,000USD | 47,065,000,000USD | 43,055,000,000USD | 44,358,000,000USD | 34,969,000,000USD | 29,074,000,000USD | -5,332,000,000USD |
| Unclassified Non Current Assets | — | -46,219,000,000USD | -47,017,000,000USD | -42,204,000,000USD | -43,780,000,000USD | -22,113,000,000USD | -17,866,000,000USD | 10,271,000,000USD |
| Inventory | — | — | -32,021,000,000USD | -27,857,000,000USD | -26,707,000,000USD | -24,779,000,000USD | -20,944,000,000USD | -3,564,000,000USD |
| Other Liab | — | — | — | 1,017,000,000USD | 2,371,000,000USD | 1,787,000,000USD | 809,000,000USD | 800,000,000USD |
| Non Current Liabilities Other | — | — | — | 1,473,000,000USD | 2,383,000,000USD | 1,787,000,000USD | 1,141,000,000USD | 800,000,000USD |
| Net Tangible Assets | — | — | — | 6,169,000,000USD | 4,988,000,000USD | 9,281,000,000USD | 8,109,000,000USD | 6,264,000,000USD |
| Treasury Stock | — | — | — | — | -10,163,000,000USD | -9,918,000,000USD | -8,455,000,000USD | -7,320,000,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | 2,371,000,000USD | 1,955,000,000USD | 1,735,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 322,000,000USD |
| Stock Based Compensation | 116,000,000USD |
| Change To Liabilities | 1,241,000,000USD |
| Change In Working Capital | 339,000,000USD |
| Operating Cash Flow | 3,220,000,000USD |
| Capital Expenditures | -253,000,000USD |
| Net Investments | -1,619,000,000USD |
| Other Investing Activities | -930,000,000USD |
| Unclassified Investing Cash Flow | -24,000,000USD |
| Investing Cash Flow | -2,826,000,000USD |
| Net Debt Issuance | 2,009,000,000USD |
| Net Common Stock Issuance | -108,000,000USD |
| Common Dividends Paid | -214,000,000USD |
| Other Financing Activities | -28,000,000USD |
| Unclassified Financing Cash Flow | 640,000,000USD |
| Financing Cash Flow | 2,299,000,000USD |
| Change In Cash | 2,693,000,000USD |
| End Cash Flow | 6,893,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,184,000,000USD | -796,000,000USD | 194,000,000USD | 543,000,000USD | 1,242,000,000USD | -686,000,000USD | 480,000,000USD | 678,000,000USD |
| Depreciation | 194,000,000USD | 194,000,000USD | 204,000,000USD | 211,000,000USD | 215,000,000USD | 240,000,000USD | 243,000,000USD | 243,000,000USD |
| Stock Based Compensation | 51,000,000USD | 48,000,000USD | 83,000,000USD | 61,000,000USD | 49,000,000USD | 54,000,000USD | 53,000,000USD | 55,000,000USD |
| Other Non Cash Items | 40,000,000USD | 312,000,000USD | 63,000,000USD | 38,000,000USD | 57,000,000USD | 174,000,000USD | 80,000,000USD | 83,000,000USD |
| Change To Account Receivables | -1,914,000,000USD | -586,000,000USD | 1,816,000,000USD | -45,000,000USD | -1,755,000,000USD | -560,000,000USD | 1,946,000,000USD | -165,000,000USD |
| Change In Working Capital | -215,000,000USD | -1,410,000,000USD | 427,000,000USD | 418,000,000USD | -1,232,000,000USD | -310,000,000USD | 1,002,000,000USD | 154,000,000USD |
| Total Cash From Operating Activities | 1,254,000,000USD | -1,652,000,000USD | 971,000,000USD | 1,271,000,000USD | 331,000,000USD | -528,000,000USD | 1,858,000,000USD | 1,213,000,000USD |
| Capital Expenditures | -121,000,000USD | -202,000,000USD | -135,000,000USD | -114,000,000USD | -95,000,000USD | -154,000,000USD | -130,000,000USD | -114,000,000USD |
| Free Cash Flow | 1,133,000,000USD | -1,854,000,000USD | 836,000,000USD | 1,157,000,000USD | 236,000,000USD | -682,000,000USD | 1,728,000,000USD | 1,099,000,000USD |
| Investments | -1,576,000,000USD | 966,000,000USD | 980,000,000USD | 347,000,000USD | 314,000,000USD | -63,000,000USD | -1,473,000,000USD | -1,002,000,000USD |
| Total Cashflows From Investing Activities | -2,553,000,000USD | 632,000,000USD | 980,000,000USD | 347,000,000USD | 314,000,000USD | -63,000,000USD | -1,473,000,000USD | -1,002,000,000USD |
| Net Borrowings | 1,673,000,000USD | -274,000,000USD | 0USD | -772,000,000USD | 1,477,000,000USD | -1,071,000,000USD | -14,000,000USD | — |
| Total Cash From Financing Activities | 2,050,000,000USD | -168,000,000USD | -603,000,000USD | -1,828,000,000USD | 1,384,000,000USD | -2,304,000,000USD | -770,000,000USD | -620,000,000USD |
| Dividends Paid | -107,000,000USD | -109,000,000USD | -107,000,000USD | -106,000,000USD | -108,000,000USD | -108,000,000USD | -107,000,000USD | -107,000,000USD |
| Sale Purchase Of Stock | -107,000,000USD | -42,000,000USD | -109,000,000USD | -100,000,000USD | -9,000,000USD | -49,000,000USD | -2,000,000USD | -49,000,000USD |
| Change In Cash | 751,000,000USD | -1,188,000,000USD | 1,348,000,000USD | -210,000,000USD | 2,029,000,000USD | -2,895,000,000USD | -385,000,000USD | -409,000,000USD |
| Begin Period Cash Flow | 4,200,000,000USD | 5,388,000,000USD | 4,040,000,000USD | 4,250,000,000USD | 2,221,000,000USD | 5,116,000,000USD | 5,501,000,000USD | 5,910,000,000USD |
| End Period Cash Flow | 4,951,000,000USD | 4,200,000,000USD | 5,388,000,000USD | 4,040,000,000USD | 4,250,000,000USD | 2,221,000,000USD | 5,116,000,000USD | 5,501,000,000USD |
| Other Cashflows From Investing Activities | 55,000,000USD | -56,000,000USD | -93,000,000USD | 127,000,000USD | -175,000,000USD | -461,000,000USD | -2,468,000,000USD | -79,000,000USD |
| Other Cashflows From Financing Activities | 591,000,000USD | 257,000,000USD | -496,000,000USD | -850,000,000USD | 24,000,000USD | -1,076,000,000USD | -647,000,000USD | -179,000,000USD |
| Unclassified Investing Cash Flow | -911,000,000USD | -76,000,000USD | 228,000,000USD | -13,000,000USD | 270,000,000USD | 615,000,000USD | 2,598,000,000USD | 193,000,000USD |
| Unclassified Financing Cash Flow | — | — | 109,000,000USD | — | — | — | — | -285,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,203,000,000USD | 1,214,000,000USD | 2,489,000,000USD | 2,802,000,000USD | 2,934,000,000USD | 3,367,000,000USD | 2,707,000,000USD | 1,683,000,000USD |
| Depreciation | 824,000,000USD | 968,000,000USD | 917,000,000USD | 845,000,000USD | 713,000,000USD | 616,000,000USD | 575,000,000USD | 534,000,000USD |
| Stock Based Compensation | 241,000,000USD | 207,000,000USD | 175,000,000USD | 216,000,000USD | 180,000,000USD | 181,000,000USD | 163,000,000USD | 137,000,000USD |
| Other Non Cash Items | 375,000,000USD | 615,000,000USD | 486,000,000USD | 290,000,000USD | -1,024,000,000USD | -863,000,000USD | 14,000,000USD | 792,000,000USD |
| Change To Account Receivables | -570,000,000USD | -669,000,000USD | -337,000,000USD | -54,000,000USD | -280,000,000USD | -85,000,000USD | -32,000,000USD | -164,000,000USD |
| Change In Working Capital | -1,797,000,000USD | 154,000,000USD | 81,000,000USD | 534,000,000USD | -556,000,000USD | 2,143,000,000USD | 1,663,000,000USD | -1,167,000,000USD |
| Total Cash From Operating Activities | 921,000,000USD | 2,966,000,000USD | 3,981,000,000USD | 4,587,000,000USD | 2,262,000,000USD | 5,639,000,000USD | 5,284,000,000USD | 2,173,000,000USD |
| Capital Expenditures | -546,000,000USD | -575,000,000USD | -1,004,000,000USD | -1,120,000,000USD | -1,316,000,000USD | -964,000,000USD | -736,000,000USD | -612,000,000USD |
| Free Cash Flow | 375,000,000USD | 2,391,000,000USD | 2,977,000,000USD | 3,467,000,000USD | 946,000,000USD | 4,675,000,000USD | 4,548,000,000USD | 1,561,000,000USD |
| Investments | 2,982,000,000USD | -2,952,000,000USD | -3,622,000,000USD | -1,006,000,000USD | -1,053,000,000USD | -1,392,000,000USD | -542,000,000USD | -1,316,000,000USD |
| Total Cashflows From Investing Activities | 2,273,000,000USD | -2,952,000,000USD | -3,492,000,000USD | -1,006,000,000USD | -6,556,000,000USD | -3,065,000,000USD | -1,278,000,000USD | -3,087,000,000USD |
| Net Borrowings | 431,000,000USD | 218,000,000USD | 423,000,000USD | -1,428,000,000USD | 3,764,000,000USD | 1,078,000,000USD | -369,000,000USD | 1,165,000,000USD |
| Total Cash From Financing Activities | -1,215,000,000USD | -2,487,000,000USD | -856,000,000USD | -1,914,000,000USD | 3,015,000,000USD | -1,955,000,000USD | -2,295,000,000USD | -785,000,000USD |
| Dividends Paid | -430,000,000USD | -431,000,000USD | -431,000,000USD | -392,000,000USD | -354,000,000USD | -323,000,000USD | -291,000,000USD | -265,000,000USD |
| Sale Purchase Of Stock | -151,000,000USD | -817,000,000USD | -1,573,000,000USD | -2,096,000,000USD | -79,000,000USD | -1,820,000,000USD | -1,070,000,000USD | -1,090,000,000USD |
| Change In Cash | 1,979,000,000USD | -2,473,000,000USD | -367,000,000USD | 1,667,000,000USD | -1,279,000,000USD | 619,000,000USD | 1,711,000,000USD | -1,699,000,000USD |
| Begin Period Cash Flow | 2,221,000,000USD | 4,694,000,000USD | 5,061,000,000USD | 3,394,000,000USD | 4,673,000,000USD | 4,054,000,000USD | 2,343,000,000USD | 4,042,000,000USD |
| End Period Cash Flow | 4,200,000,000USD | 2,221,000,000USD | 4,694,000,000USD | 5,061,000,000USD | 3,394,000,000USD | 4,673,000,000USD | 4,054,000,000USD | 2,343,000,000USD |
| Other Cashflows From Investing Activities | -82,000,000USD | -461,000,000USD | 210,000,000USD | 114,000,000USD | -5,240,000,000USD | -709,000,000USD | -542,000,000USD | -2,121,000,000USD |
| Other Cashflows From Financing Activities | -1,065,000,000USD | -1,457,000,000USD | 725,000,000USD | 3,574,000,000USD | -337,000,000USD | -939,000,000USD | -623,000,000USD | -595,000,000USD |
| Unclassified Operating Cash Flow | 75,000,000USD | -192,000,000USD | -167,000,000USD | -100,000,000USD | — | 195,000,000USD | 162,000,000USD | 194,000,000USD |
| Unclassified Investing Cash Flow | -81,000,000USD | 1,036,000,000USD | 924,000,000USD | 1,006,000,000USD | 1,053,000,000USD | — | 542,000,000USD | 962,000,000USD |
| Change To Inventory | — | — | -364,000,000USD | — | 280,000,000USD | — | — | — |
| Change To Liabilities | — | — | — | 1,019,000,000USD | -65,000,000USD | 2,738,000,000USD | 1,613,000,000USD | -424,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 1,667,000,000USD | -1,279,000,000USD | 619,000,000USD | 1,711,000,000USD | -1,699,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | -1,572,000,000USD | — | 49,000,000USD | 58,000,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2024Quarterly · 2024-09-30 | Product | External Revenues | 29,054,000,000 | USD | 0000049071-24-000055 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other | 4,508,000,000 | USD | 0000049071-24-000055 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | -2,701,000,000 | USD | 0000049071-24-000055 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | -1,464,000,000 | USD | 0000049071-24-000055 |
| Q2 2024Quarterly · 2024-06-30 | Product | External Revenues | 29,242,000,000 | USD | 0000049071-24-000040 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other | 4,360,000,000 | USD | 0000049071-24-000040 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | -2,645,000,000 | USD | 0000049071-24-000040 |
| Q2 2024Quarterly · 2024-06-30 | Product | Services | -1,417,000,000 | USD | 0000049071-24-000040 |
| Q1 2024Quarterly · 2024-03-31 | Product | External Revenues | 29,323,000,000 | USD | 0000049071-24-000023 |
| Q1 2024Quarterly · 2024-03-31 | Product | Other | 4,320,000,000 | USD | 0000049071-24-000023 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | -2,617,000,000 | USD | 0000049071-24-000023 |
| Q1 2024Quarterly · 2024-03-31 | Product | Services | -1,415,000,000 | USD | 0000049071-24-000023 |
| Q4 2023Quarterly · 2023-12-31 | Product | External Revenues | 26,168,000,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Other | 4,235,000,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Product | -2,603,000,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Services | -1,338,000,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | External Revenues | 105,305,000,000 | USD | 0000049071-24-000012 |
| FY 2023Yearly · 2023-12-31 | Product | Other | 16,472,000,000 | USD | 0000049071-24-000012 |
| FY 2023Yearly · 2023-12-31 | Product | Product | -10,451,000,000 | USD | 0000049071-24-000012 |
| FY 2023Yearly · 2023-12-31 | Product | Services | -4,952,000,000 | USD | 0000049071-24-000012 |
| Q3 2023Quarterly · 2023-09-30 | Product | External Revenues | 26,115,000,000 | USD | 0000049071-24-000055 |
| Q3 2023Quarterly · 2023-09-30 | Product | Other | 4,210,000,000 | USD | 0000049071-24-000055 |
| Q3 2023Quarterly · 2023-09-30 | Product | Product | -2,594,000,000 | USD | 0000049071-24-000055 |
| Q3 2023Quarterly · 2023-09-30 | Product | Services | -1,308,000,000 | USD | 0000049071-24-000055 |
| Q2 2023Quarterly · 2023-06-30 | Product | External Revenues | 26,473,000,000 | USD | 0000049071-24-000040 |
| Q2 2023Quarterly · 2023-06-30 | Product | Other | 4,072,000,000 | USD | 0000049071-24-000040 |
| Q2 2023Quarterly · 2023-06-30 | Product | Product | -2,639,000,000 | USD | 0000049071-24-000040 |
| Q2 2023Quarterly · 2023-06-30 | Product | Services | -1,159,000,000 | USD | 0000049071-24-000040 |
| Q1 2023Quarterly · 2023-03-31 | Product | External Revenues | 26,549,000,000 | USD | 0000049071-24-000023 |
| Q1 2023Quarterly · 2023-03-31 | Product | Other | 3,955,000,000 | USD | 0000049071-24-000023 |
| Q1 2023Quarterly · 2023-03-31 | Product | Product | -2,615,000,000 | USD | 0000049071-24-000023 |
| Q1 2023Quarterly · 2023-03-31 | Product | Services | -1,147,000,000 | USD | 0000049071-24-000023 |
| FY 2022Yearly · 2022-12-31 | Product | External Revenues | 92,488,000,000 | USD | 0000049071-24-000012 |
| FY 2022Yearly · 2022-12-31 | Product | Other | 13,811,000,000 | USD | 0000049071-24-000012 |
| FY 2022Yearly · 2022-12-31 | Product | Product | -9,841,000,000 | USD | 0000049071-24-000012 |
| FY 2022Yearly · 2022-12-31 | Product | Services | -3,588,000,000 | USD | 0000049071-24-000012 |
| Q3 2022Quarterly · 2022-09-30 | Product | External Revenues | 22,627,000,000 | USD | 0000049071-23-000064 |
| Q3 2022Quarterly · 2022-09-30 | Product | Other | 3,508,000,000 | USD | 0000049071-23-000064 |
| Q3 2022Quarterly · 2022-09-30 | Product | Product | -2,459,000,000 | USD | 0000049071-23-000064 |
| Q3 2022Quarterly · 2022-09-30 | Product | Services | -877,000,000 | USD | 0000049071-23-000064 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Group And Specialty | 196,000,000 | USD | 0000049071-22-000057 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Healthcare Services | 1,145,000,000 | USD | 0000049071-22-000057 |
| Q2 2022Quarterly · 2022-06-30 | Segment | Retail | 8,000,000 | USD | 0000049071-22-000057 |
| Q1 2022Quarterly · 2022-03-31 | Segment | Group And Specialty | 195,000,000 | USD | 0000049071-22-000032 |
| Q1 2022Quarterly · 2022-03-31 | Segment | Healthcare Services | 1,063,000,000 | USD | 0000049071-22-000032 |
| Q1 2022Quarterly · 2022-03-31 | Segment | Retail | 6,000,000 | USD | 0000049071-22-000032 |
| FY 2021Yearly · 2021-12-31 | Product | External Revenues | 82,877,000,000 | USD | 0000049071-24-000012 |
| FY 2021Yearly · 2021-12-31 | Product | Other | 12,080,000,000 | USD | 0000049071-24-000012 |
| FY 2021Yearly · 2021-12-31 | Product | Product | -9,024,000,000 | USD | 0000049071-24-000012 |
| FY 2021Yearly · 2021-12-31 | Product | Services | -2,869,000,000 | USD | 0000049071-24-000012 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Group And Specialty | 198,000,000 | USD | 0000049071-22-000071 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Healthcare Services | 647,000,000 | USD | 0000049071-22-000071 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Retail | 0 | USD | 0000049071-22-000071 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Group And Specialty | 194,000,000 | USD | 0000049071-22-000057 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Healthcare Services | 285,000,000 | USD | 0000049071-22-000057 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Retail | 12,000,000 | USD | 0000049071-22-000057 |
| Q1 2021Quarterly · 2021-03-31 | Segment | Group And Specialty | 190,000,000 | USD | 0000049071-22-000032 |
| Q1 2021Quarterly · 2021-03-31 | Segment | Healthcare Services | 271,000,000 | USD | 0000049071-22-000032 |
| Q1 2021Quarterly · 2021-03-31 | Segment | Retail | 5,000,000 | USD | 0000049071-22-000032 |
| Q4 2020Quarterly · 2020-12-31 | Segment | Group And Specialty | 204,000,000 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-12-31 | Segment | Healthcare Services | 275,000,000 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-12-31 | Segment | Retail | 5,000,000 | USD | Legacy provider |
| FY 2020Yearly · 2020-12-31 | Segment | Group And Specialty | 780,000,000 | USD | 0000049071-22-000017 |
| FY 2020Yearly · 2020-12-31 | Segment | Healthcare Services | 1,016,000,000 | USD | 0000049071-22-000017 |
| FY 2020Yearly · 2020-12-31 | Segment | Retail | 19,000,000 | USD | 0000049071-22-000017 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Group And Specialty | 189,000,000 | USD | 0000049071-21-000136 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Healthcare Services | 264,000,000 | USD | 0000049071-21-000136 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Retail | 4,000,000 | USD | 0000049071-21-000136 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Group And Specialty | 192,000,000 | USD | 0000049071-21-000112 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Healthcare Services | 252,000,000 | USD | 0000049071-21-000112 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Retail | 6,000,000 | USD | 0000049071-21-000112 |
| FY 2019Yearly · 2019-12-31 | Segment | Group And Specialty | 790,000,000 | USD | 0000049071-22-000017 |
| FY 2019Yearly · 2019-12-31 | Segment | Healthcare Services | 632,000,000 | USD | 0000049071-22-000017 |
| FY 2019Yearly · 2019-12-31 | Segment | Retail | 17,000,000 | USD | 0000049071-22-000017 |
| FY 2018Yearly · 2018-12-31 | Segment | Group And Specialty | 835,000,000 | USD | 0000049071-21-000039 |
| FY 2018Yearly · 2018-12-31 | Segment | Healthcare Services | 607,000,000 | USD | 0000049071-21-000039 |
| FY 2018Yearly · 2018-12-31 | Segment | Individual Commercial | 0 | USD | 0000049071-21-000039 |
| FY 2018Yearly · 2018-12-31 | Segment | Other | 4,000,000 | USD | 0000049071-21-000039 |
| FY 2018Yearly · 2018-12-31 | Segment | Retail | 11,000,000 | USD | 0000049071-21-000039 |
| FY 2017Yearly · 2017-12-31 | Segment | Group And Specialty | 626,000,000 | USD | 0000049071-20-000032 |
| FY 2017Yearly · 2017-12-31 | Segment | Healthcare Services | 338,000,000 | USD | 0000049071-20-000032 |
| FY 2017Yearly · 2017-12-31 | Segment | Individual Commercial | 0 | USD | 0000049071-20-000032 |
| FY 2017Yearly · 2017-12-31 | Segment | Other | 8,000,000 | USD | 0000049071-20-000032 |
| FY 2017Yearly · 2017-12-31 | Segment | Retail | 10,000,000 | USD | 0000049071-20-000032 |
| FY 2016Yearly · 2016-12-31 | Segment | Group And Specialty | 643,000,000 | USD | 0000049071-19-000023 |
| FY 2016Yearly · 2016-12-31 | Segment | Healthcare Services | 310,000,000 | USD | 0000049071-19-000023 |
| FY 2016Yearly · 2016-12-31 | Segment | Individual Commercial | 0 | USD | 0000049071-19-000023 |
| FY 2016Yearly · 2016-12-31 | Segment | Other | 10,000,000 | USD | 0000049071-19-000023 |
| FY 2016Yearly · 2016-12-31 | Segment | Retail | 6,000,000 | USD | 0000049071-19-000023 |
| FY 2015Yearly · 2015-12-31 | Segment | Group And Specialty | 7,488,000,000 | USD | 0000049071-18-000014 |
| FY 2015Yearly · 2015-12-31 | Segment | Healthcare Services | 726,000,000 | USD | 0000049071-18-000014 |
| FY 2015Yearly · 2015-12-31 | Segment | Individual Commercial | 3,939,000,000 | USD | 0000049071-18-000014 |
| FY 2015Yearly · 2015-12-31 | Segment | Retail | 41,613,000,000 | USD | 0000049071-18-000014 |
| FY 2014Yearly · 2014-12-31 | Segment | Group | 7,219,000,000 | USD | 0000049071-17-000019 |
| FY 2014Yearly · 2014-12-31 | Segment | Healthcare Services | 1,353,000,000 | USD | 0000049071-17-000019 |
| FY 2014Yearly · 2014-12-31 | Segment | Other | 60,000,000 | USD | 0000049071-17-000019 |
| FY 2014Yearly · 2014-12-31 | Segment | Retail | 39,491,000,000 | USD | 0000049071-17-000019 |
| FY 2013Yearly · 2013-12-31 | Segment | Group | 6,972,000,000 | USD | 0000049071-16-000117 |
| FY 2013Yearly · 2013-12-31 | Segment | Healthcare Services | 1,350,000,000 | USD | 0000049071-16-000117 |
| FY 2013Yearly · 2013-12-31 | Segment | Other Businesses | 676,000,000 | USD | 0000049071-16-000117 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.